HomeCERS • NASDAQ
Cerus Corp
add
$1.29
3.61%
After Hours:(0.78%)-0.0100
$1.28
Closed: Aug 12, 6:01:33 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 52.45M | 16.34% |
Operating expense | 32.40M | 13.67% |
Net income | -5.71M | 1.18% |
Net profit margin | -10.88 | 15.07% |
Earnings per share | -0.03 | 0.00% |
EBITDA | -3.08M | 8.25% |
Effective tax rate | -1.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.03M | 9.59% |
Total assets | 213.07M | 14.87% |
Total liabilities | 156.90M | 16.06% |
Total equity | 56.17M | — |
Shares outstanding | 191.70M | — |
Price to book | 4.29 | — |
Return on assets | -4.08% | — |
Return on capital | -5.51% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.71M | 1.18% |
Cash from operations | -2.45M | -709.98% |
Cash from investing | -1.09M | 84.68% |
Cash from financing | -129.00K | 90.81% |
Net change in cash | -3.45M | 57.49% |
Free cash flow | -6.96M | -110.07% |
Previous close
$1.25
Day range
$1.25 - $1.31
Year range
$1.12 - $2.39
Market cap
246.30M USD
Avg Volume
968.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Headquarters
Website
Employees
622
